2023 HIV Avenir Symposium



Additional Information

The NIDA HIV Research Program invites you to a symposium featuring innovative research at the nexus of HIV and substance use disorders led by recipients of Avenir Award Program (DP2) grants (PAR-23-125).

  • Joshua Barocas, M.D., University of Colorado School of Medicine
    Rethinking What Information Matters and How People Get Counted to Reduce Overdose Deaths
  • Christina Meade, Ph.D., Wake Forest University School of Medicine
    HIV and Substance Use Comorbidity: From Social to Neural Networks
  • Pablo Penaloza-MacMaster, Ph.D., Northwestern University
    Developing IFN-Modulated Vaccines to Prevent Intravenous Infections
  • Alon Herschhorn, Ph.D., University of Minnesota
    Delineation and Vulnerabilities of HIV-1 Escape from Neutralizing Antibodies

You can review the 2022 Avenir Symposium and the 2021 Avenir Symposium, providing insights into other groundbreaking early-stage investigators at the intersection of HIV and substance use. 

HRP also funds the complementary Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research to support potentially transformative studies by investigators at all career levels.

Contact HIVNews@nida.nih.gov for more information and updates on the HIV Avenir and Avant-Garde Awards.

Upcoming Meetings/Events